pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    clascoterone
    Winlevi (clascoterone)
    Acne Vulgaris Sun Pharmaceutical Industries Ltd
  • Phase 2
    claseprubart
    claseprubart[INN]
    Myasthenia Gravis Dianthus Therapeutics Inc
  • Phase 3
    clazakizumab
    clazakizumab
    End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)$CSLLY CSL LTD
  • Marketed
← prev
page 166 of 231
next →
131
Pain89
Neurology1
clemastine fumarate
Clemastine Fumarate
Chronic Urticaria
Genus Lifesciences Inc
  • Phase 2
    cleminorexton
    cleminorexton [INN]
    Idiopathic Hypersomnia (IH)$CNTA Centessa Pharmaceuticals plc
  • Phase 3
    clemizole hydrochloride
    clemizole hydrochloride
    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)$HRMY Harmony Biosciences Holdings, Inc.
  • Phase 2
    clenbuterol
    clenbuterol [INN]
    Pompe Disease$ATXI AVENUE THERAPEUTICS, INC.
  • Marketed
    clesrovimab
    Enflonsia (clesrovimab-cfor)
    Respiratory Syncytial Virus (RSV) Infections$MRK Merck & Co., Inc.
  • Marketed
    clevidipine
    Cleviprex (clevidipine)
    Hypertension Chiesi USA Inc
  • Marketed
    clindamycin palmitate hydrochloride
    Clindamycin Palmitate Hydrochloride
    Skin And Soft Tissue Infections Somerset Therapeutics LLC
  • Phase 3
    cliramitug
    cliramitug
    Amyloid Cardiomyopathy Alexion Pharmaceuticals Inc
  • Marketed
    clobazam
    Clobazam
    Lennox-Gastaut Syndrome Taro Pharmaceutical Laboratories Inc (Inactive)
  • Marketed
    clocortolone pivalate
    Clocortolone Pivalate Dr.Reddy's (clocortolone pivalate)
    Psoriasis Dr. Reddy's Laboratories Ltd
  • Preclinical
    clofarabine
    Clofarabine Winthrop (clofarabine)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) BoYen Therapeutics Inc
  • Marketed
    clomipramine hydrochloride
    Clomipramine Hydrochloride
    Obsessive-Compulsive Disorder TruPharma LLC
  • Marketed
    clonazepam ODT
    Clonazepam
    Agoraphobia Endo Pharmaceuticals Inc
  • Marketed
    clopidogrel bisulfate
    Clopidogrel Bisulfate
    Acute Coronary Syndrome Ascend Laboratories Ltd
  • Marketed
    clorazepate dipotassium
    Tranxene (clorazepate dipotassium)
    Alcohol Withdrawal Syndrome Recordati Rare Diseases Inc
  • Marketed
    clotrimazole
    Clotrimazole
    Vulvovaginal Candidiasis PL Developments Copiague LLC
  • Marketed
    coagulation factor IX (human)
    AlphaNine SD (coagulation factor IX (human))
    Hemophilia B (Factor IX Deficiency) Grifols Biologicals Inc (Inactive)
  • Marketed
    coagulation factor IX (recombinant)
    Ixinity (coagulation factor IX (recombinant))
    Hemophilia B (Factor IX Deficiency) Medexus Pharma Inc
  • Marketed
    coagulation factor IX (recombinant), Fc fusion protein LA
    Alprolix (coagulation factor IX (recombinant), Fc fusion protein)
    Hemophilia B (Factor IX Deficiency) Sanofi-Aventis US LLC
  • Marketed
    coagulation factor IX (recombinant), glycopegylated LA
    Rebinyn (coagulation factor IX (recombinant), glycopegylated)
    Hemophilia B (Factor IX Deficiency) Novo Nordisk Inc
  • Marketed
    coagulation factor VIII (human)
    Koate DVI (coagulation factor VIII (human))
    Hemophilia A (Factor VIII Deficiency) Kedrion Biopharma Inc
  • Marketed
    coagulation factor VIIa (recombinant)
    Sevenfact (coagulation factor VIIa (recombinant)-jncw)
    Hemophilia A (Factor VIII Deficiency) Hema Biologics LLC
  • Phase 3
    coagulation factor X (human)
    Coagadex (coagulation factor X (human))
    Stuart Prower Factor Deficiency (Factor X Deficiency) Kedrion SpA
  • Marketed
    coagulation factor XIII A-subunit (recombinant)
    Tretten (coagulation factor XIII A-subunit (recombinant))
    Fibrin Stabilizing Factor Deficiency (Factor XIII Deficie… Novo Nordisk Inc
  • Marketed
    cobicistat
    Tybost (cobicistat)
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$GILD GILEAD SCIENCES, INC.
  • Marketed
    cobimetinib fumarate
    Cotellic (cobimetinib fumarate)
    Erdheim-Chester Disease (Erdheim–Chester Syndrome/ Polyos… Genentech Inc
  • Preclinical
    cobinamide
    Marfan Syndrome Mesa Science Associates Inc